AMPH vs TLRY

AMPH exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability, though the absence of an Altman Z-Score raises concern about default risk. The stock trades at a discount to its Graham Number ($28.09) and intrinsic value ($14.21), suggesting undervaluation on a defensive basis. However, this is overshadowed by deteriorating fundamentals: negative revenue and earnings growth (YoY -1.8% and -31.0%), declining quarterly earnings, and a significant 36.4% drop in price over the past month. Insider selling activity further undermines confidence, with $0.95M in sales over six months despite no buy activity.

Tilray Brands exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating a company in financial distress. The firm suffers from catastrophic profitability metrics, including a profit margin of -156.66% and a total failure to beat earnings estimates in the last four quarters (0/4). While a strong current ratio of 2.79 provides a temporary liquidity buffer, the long-term trajectory is characterized by massive value destruction, with a 5-year price decline of 95.8%. The disconnect between the 'Buy' analyst consensus and the deterministic health scores suggests the stock is being traded on speculative regulatory hopes rather than operational performance.